19 Oct Key takeaways for developing COVID vaccine management
by Dr. Suman De
The COVID-19 pandemic has claimed over 1 million lives and created 38 million cases worldwide to date. That is far too many. While the scientific community and countless clinical trials do all they can to get a safe vaccine approved and into the market, the entire healthcare space at large must prepare for a dizzying maze of immunization logistics. As this blog series has shown, there are many new considerations, concerns, and functionalities an effective COVID-19 vaccine management program must address.
The Infosys Vaccination Management (IVM) solution is one-of-a-kind and the ideal platform for public health departments coordinating vaccine programs because of its comprehensive design and end-to-end approach. In that way, it is really the platform for effectively managing the COVID vaccine program. There are three strategic advantages to utilizing the IVM solution: process simplification to ease end user adoption and scale, integrated capabilities that enrich usability and experience, and continuous improvement to lower operational cost. I’d like to discuss each one for a complete understanding of the IVM offering.
Perhaps the biggest initial benefit to the IVM solution is how it simplifies complex vaccine program processes. By automating various workflows, the platform allows citizens, vaccine administrators, providers, public health department staff, epidemiologists, and data analysts to onboard with ease. Whether their daily function is to handle registration, scheduling, enrollment, clinical documentation, data management, reporting, or analytics, users of the IVM platform will quickly notice how simple, often tedious, manual tasks are with the efficient automated features of IVM.
Additionally, the process simplification of IVM helps to make operations more streamlined, consistent, and scalable. It helps to gain productivity by significantly reducing rework (e.g., mass candidate registration, provider enrollment, vaccine, running advocacy campaigns, vaccine administration documentation, adverse event case management, etc.). This introduces more self-service capabilities that eventually free up the time of service providers like vaccination clinic nurses, doctors, public health caseworkers, or customer service reps, which means that they have increased availability to focus on providing top-notch citizen services. Equally, it benefits the heavy backend duties (e.g., inventory management, order submission, vaccine allocation, routine data capture, report submission, record-keeping, or data analysis) by systematically reducing the number of…
Want to keep reading? Check out the full ebook here: The Complete Guide to COVID-19 Vaccine Management.
Dr. De is Infosys Public Services’ Head for Government Healthcare Solutions. In this capacity, he is responsible for the ideation and development of next-generation solutions for public health agencies. He has vast experience in the public health domain, and his previous work experience ranges from involvement with Govt. of India’s National pulse polio immunization program in collaboration with the World Health Organization and various other public health projects conducted by international organizations like UNICEF, Indian Public Health Association, etc. He has been recognized as a subject matter expert (SME) in healthcare for his contribution to the industry through thought leadership, points of view, articles, workshops, running webinars, and speaking sessions. Dr. De is a graduate in medicine from India and holds a Masters in Healthcare Administration from a premier business school in India. He is the recipient of several awards of excellence in recognition of his work for the healthcare industry.